TF and neoplasm: Experimental results indicated that Tf-Pen liposomes significantly increased drug accumulation in brain tumors, with approximately 12-fold enhancement for Dox and approximately 3.3-fold for Erlo, while demonstrating favorable anti-tumor effects—over 90% tumor regression—and extending the median survival time of mice to 36 days (90, 91).